Synchronous breast cancers with different morphologic and molecular phenotypes occurring in lynch syndrome: What does the heterogeneity imply?

American Journal of Surgical Pathology

Volumn 35, Issue 11, 2011, Pages 1743-1748

  D'Arcy, Clare ^a   Wen, Yong H ^a   Stadler, Zsofia K ^a   Brogi, Edi ^a   Shia, Jinru ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

hereditary nonpolyposis colorectal cancer syndrome; lobular breast carcinoma; microsatellite instability; mismatch repair defi ciency

Indexed keywords

DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MSH2 PROTEIN, HUMAN; PROTEIN MSH2; TUMOR MARKER;

AGED; ARTICLE; BREAST TUMOR; CASE REPORT; CHEMISTRY; FEMALE; GENETICS; GENOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MISMATCH REPAIR; MULTIPLE CANCER; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; TUMOR ASSOCIATED LEUKOCYTE;

AGED; BREAST NEOPLASMS; CARCINOMA, LOBULAR; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL;

EID: 80054997206     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182320cff     Document Type: Article

References (37)

1. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35-41.
2. AarnioM, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999;81:214-218. (Pubitemid 29144749)
3. Akoum R, Ghaoui A, Brihi E, et al. Early-onset breast cancer in a Lebanese family with Lynch syndrome due to MSH2 gene mutation. Hered Cancer Clin Pract. 2009;7:10.
4. Anbazhagan R, Fujii H, Gabrielson E. Microsatellite instability is uncommon in breast cancer. Clin Cancer Res. 1999;5:839-844. (Pubitemid 29180836)
5. Berends MJ, Cats A, Hollema H, et al. Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation? Hum Pathol. 2000;31:1522-1527. (Pubitemid 32047005)
6. Bergthorsson JT, Egilsson V, Gudmundsson J, et al. Identification of a breast tumor with microsatellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait. Clin Genet. 1995;47:305-310.
7. Boland CR, Shike M. Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. Gastroenterology. 2010;138:e2191-e2197.
8. Boyd J, Rhei E, Federici MG, et al. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat. 1999;53:87-91. (Pubitemid 29123623)
9. Broaddus RR, Lynch PM, Lu KH, et al. Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol. 2004;17:981-989. (Pubitemid 38993783)
10. da Silva FC, de Oliveira LP, Santos EM, et al. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer. 2010;9:563-570.
11. de Leeuw WJ, van Puijenbroek M, Tollenaar RA, et al. Correspondence re: A. Muller et al, Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res. 2002;62:1014-1019.
12. Cancer Res. 2003;63:1148-1149.
13. Edge S, Byrd DR, Carducci MA, Compton CC. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
14. Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol. 1992;23:655-662.
15. Jensen UB, Sunde L, Timshel S, et al. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat. 2010;120:777-782.
16. Lakhani SR, Jacquemier J, Sloane JP, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998;90:1138-1145. (Pubitemid 28380718)
17. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3:467-488. (Pubitemid 10201560)
18. Offit K, Kauff ND. Reducing the risk of gynecologic cancer in the Lynch syndrome. N Engl J Med. 2006;354:293-295. (Pubitemid 43113037)
19. Risinger JI, Barrett JC, Watson P, et al. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer. 1996;77:1836-1843. (Pubitemid 26125184)
20. Scott RJ, McPhillips M, Meldrum CJ, et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet. 2001;68:118-127. (Pubitemid 32048366)
21. Seitz S, Wassmuth P, Plaschke J, et al. Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines. Genes Chromosomes Cancer. 2003;37:29-35. (Pubitemid 36417919)
22. Shanley S, Fung C, Milliken J, et al. Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam Cancer. 2009;8:251-255.
23. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10:293-300. (Pubitemid 352019113)
24. Shia J, Ellis NA, Paty PB, et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol. 2003;27:1407-1417. (Pubitemid 37315192)
25. Sijmons R, Hofstra R, Hollema H, et al. Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer. Genes Chromosomes Cancer. 2000;29:353-355.
26. Tavassoeli FA, Devilee P. World Health Organization Classification of Tumours Pathology and Genetics Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
27. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004; 96:261-268. (Pubitemid 38256271)
28. Vasen HF, Morreau H, Nortier JW. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet. 2001;68:1533-1535. (Pubitemid 32510631)
29. Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353-362. (Pubitemid 46953715)
30. Walsh MD, Buchanan DD, Cummings MC, et al. Lynch syndromeassociated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010; 16:2214-2224.
31. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677-685. (Pubitemid 23051366)
32. Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol. 1992;23:1167-1171.
33. Westenend PJ, Schutte R, Hoogmans MM, et al. Breast cancer in an MSH2 gene mutation carrier. Hum Pathol. 2005;36:1322-1326. (Pubitemid 41682289)
34. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
35. Yee CJ, Roodi N, Verrier CS, et al. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 1994;54: 1641-1644. (Pubitemid 24116161)
36. Yu VP, Novelli M, Payne SJ, et al. Unusual presentation of Lynch Syndrome. Hered Cancer Clin Pract. 2009;7:12.
37. Zhang L. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn. 2008; 10:301-307. (Pubitemid 352019114)